All Stories

  1. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops

    Article • Vaccine, November 2023, Elsevier

    Dr Kurt Hanevik

  2. Reduced Plasma Guanylin Levels Following Enterotoxigenic Escherichia coli-Induced Diarrhea

    Article • Microorganisms, August 2023, MDPI AG

    Dr Kurt Hanevik

  3. Dynamics of circulating lymphocytes responding to human experimental enterotoxigenic Escherichia coli infection

    Article • European Journal of Immunology, June 2023, Wiley

    Dr Kurt Hanevik

  4. Genetic diversity in the metronidazole metabolism genes nitroreductases and pyruvate ferredoxin oxidoreductases in susceptible and refractory clinical samples of Giardia lamblia

    Article • International Journal for Parasitology Drugs and Drug Resistance, April 2023, Elsevier

    Dr Kurt Hanevik

  5. Highly contiguous genomes of human clinical isolates of Giardia duodenalis reveal assemblage- and sub-assemblage-specific presence–absence variation in protein-coding genes

    Article • Microbial Genomics, March 2023, Society for General Microbiology

    Dr Kurt Hanevik

  6. Strong Association between Diarrhea and Concentration of Enterotoxigenic Escherichia coli Strain TW10722 in Stools of Experimentally Infected Volunteers

    Article • Pathogens, February 2023, MDPI AG

    Dr Kurt Hanevik

  7. Oocyst Shedding Dynamics in Children with Cryptosporidiosis: a Prospective Clinical Case Series in Ethiopia

    Article • Microbiology Spectrum, August 2022, ASM Journals

    Dr Kurt Hanevik

  8. A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: A case-case-control study in Ethiopian children

    Article • PLoS Neglected Tropical Diseases, June 2022, PLOS

    Dr Øystein Haarklau Johansen, Dr Kurt Hanevik

  9. Conserved metabolic enzymes as vaccine antigens for giardiasis

    Article • PLoS Neglected Tropical Diseases, April 2022, PLOS

    Dr Kurt Hanevik

  10. Transition to PCR diagnosis of cryptosporidiosis and giardiasis in the Norwegian healthcare system: could the increase in reported cases be due to higher sensitivity or a change in the testing algorithm?

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2022, Springer Science + Business Media

    Dr Kurt Hanevik

  11. No difference in serum levels of B‐cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post‐infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection

    Article • JGH Open, March 2022, Wiley

    Dr Kurt Hanevik

  12. Characterization of Glycosylation-Specific Systemic and Mucosal IgA Antibody Responses to Escherichia coli Mucinase YghJ (SslE)

    Article • Frontiers in Immunology, December 2021, Frontiers

    Dr Kurt Hanevik

  13. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

    Article • Nature Genetics, November 2021, Springer Science + Business Media

    Dr Kurt Hanevik

  14. A site assessment tool for inpatient controlled human infection models for enteric disease pathogens

    Article • Clinical Trials, October 2021, SAGE Publications

    Dr Kurt Hanevik

  15. Prevalence of fibromyalgia 10 years after infection with Giardia lamblia: a controlled prospective cohort study

    Article • Scandinavian Journal of Pain, October 2021, De Gruyter

    Dr Kurt Hanevik

  16. Clinical features of gastroenteritis during a large waterborne Campylobacter outbreak in Askøy, Norway

    Article • Infection, July 2021, Springer Science + Business Media

    Dr Kurt Hanevik

  17. Performance and operational feasibility of two diagnostic tests for cryptosporidiosis in children (CRYPTO-POC): a clinical, prospective, diagnostic accuracy study

    Article • The Lancet Infectious Diseases, May 2021, Elsevier

    Dr Kurt Hanevik

  18. Characteristics of hospitalized patients during a large waterborne outbreak of Campylobacter jejuni in Norway

    Article • PLoS ONE, March 2021, PLOS

    Dr Kurt Hanevik

  19. <p>Genetic Diversity of the Flavohemoprotein Gene of Giardia lamblia: Evidence for High Allelic Heterozygosity and Copy Number Variation</p>

    Article • Infection and Drug Resistance, December 2020, Taylor & Francis

    Dr Kurt Hanevik

  20. The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting

    Article • Applied and Environmental Microbiology, November 2020, ASM Journals

    Dr Kurt Hanevik

  21. Bacteraemia, Malaria, and Case Fatality Among Children Hospitalized With Fever in Dar es Salaam, Tanzania

    Article • Frontiers in Microbiology, September 2020, Frontiers

    Dr Kurt Hanevik, NAHYA SALIM MASOUD

  22. Human Mucosal IgA Immune Responses against Enterotoxigenic Escherichia coli

    Article • Pathogens, August 2020, MDPI AG

    Dr Kurt Hanevik

  23. Giardiasis treatment: an update with a focus on refractory disease

    Article • Current Opinion in Infectious Diseases, August 2020, Wolters Kluwer Health

    Dr Kurt Hanevik

  24. Comparative expression profiling in the intestine of patients with Giardia ‐induced postinfectious functional gastrointestinal disorders

    Article • Neurogastroenterology & Motility, May 2020, Wiley

    Dr Kurt Hanevik

  25. Plasma levels of guanylins are reduced in patients with Crohn’s disease

    Article • Scandinavian Journal of Gastroenterology, April 2020, Taylor & Francis

    Dr Kurt Hanevik

  26. Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and β-glucan

    Article • PLoS ONE, February 2020, PLOS

    Dr Kurt Hanevik

  27. Whole blood preservation methods alter chemokine receptor detection in mass cytometry experiments

    Article • Journal of Immunological Methods, January 2020, Elsevier

    Dr Kurt Hanevik

  28. A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea – dose optimization, clinical outcomes, and CD4+ T cell responses

    Article • PLoS Neglected Tropical Diseases, October 2019, PLOS

    Dr Kurt Hanevik

  29. Prolonged and persistent diarrhoea is not restricted to children with acute malnutrition: an observational study in Ethiopia

    Article • Tropical Medicine & International Health, August 2019, Wiley

    Dr Kurt Hanevik

  30. The way forward for ETEC controlled human infection models (CHIMs)

    Article • Vaccine, August 2019, Elsevier

    Dr Kurt Hanevik

  31. Assessment of malaria real-time PCR methods and application with focus on low-level parasitaemia

    Article • PLoS ONE, July 2019, PLOS

    Dr Kurt Hanevik

  32. Experimental Infection of Human Volunteers with the Heat-Stable Enterotoxin-Producing Enterotoxigenic Escherichia coli Strain TW11681

    Article • Pathogens, June 2019, MDPI AG

    Dr Kurt Hanevik

  33. Identification of Conserved Candidate Vaccine Antigens in the Surface Proteome of Giardia lamblia

    Article • Infection and Immunity, June 2019, ASM Journals

    Dr Kurt Hanevik

  34. Genetic variation in metronidazole metabolism and oxidative stress pathways in clinical Giardia lamblia assemblage A and B isolates

    Article • Infection and Drug Resistance, May 2019, Dove Medical Press

    Dr Kurt Hanevik

  35. Quality of life and its association with irritable bowel syndrome and fatigue ten years after giardiasis

    Article • Neurogastroenterology & Motility, February 2019, Wiley

    Dr Kurt Hanevik

  36. Prolonged Duodenal Mucosal Lymphocyte Alterations in Patients With and Without Postinfectious Functional Gastrointestinal Disorders After Giardia Infection

    Article • The Journal of Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Kurt Hanevik

  37. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea

    Article • Scandinavian Journal of Gastroenterology, October 2018, Taylor & Francis

    Dr Khanh Do-Cong Pham, Morten H Vatn, Dr Kurt Hanevik

  38. Proliferation of enterotoxigenic Escherichia coli strain TW11681 in stools of experimentally infected human volunteers

    Article • Gut Pathogens, October 2018, Springer Science + Business Media

    Dr Kurt Hanevik

  39. Treatment-refractory giardiasis: challenges and solutions

    Article • Infection and Drug Resistance, October 2018, Dove Medical Press

    Dr Kurt Hanevik

  40. Longitudinal cohort study of serum antibody responses towards Giardia lamblia variant-specific surface proteins in a non-endemic area

    Article • Experimental Parasitology, August 2018, Elsevier

    Dr Kurt Hanevik

  41. Prevalence of Irritable Bowel Syndrome and Chronic Fatigue 10 Years After Giardia Infection

    Article • Clinical Gastroenterology and Hepatology, July 2018, Elsevier

    Dr Kurt Hanevik

  42. Transient elevation of anti-transglutaminase and anti-endomysium antibodies in Giardia infection

    Article • Scandinavian Journal of Gastroenterology, June 2018, Taylor & Francis

    Dr Kurt Hanevik

  43. Giardiasis: a diagnosis that should be considered regardless of the setting

    Article • Epidemiology and Infection, June 2018, Cambridge University Press

    Dr Kurt Hanevik

  44. Genetic variation in potential Giardia vaccine candidates cyst wall protein 2 and α1-giardin

    Article • Parasitology Research, June 2017, Springer Science + Business Media

    Dr Kurt Hanevik

  45. Comprehensive Analysis of Prevalence, Epidemiologic Characteristics, and Clinical Characteristics of Monoinfection and Coinfection in Diarrheal Diseases in Children in Tanzania

    Article • American Journal of Epidemiology, May 2017, Oxford University Press (OUP)

    Dr Kurt Hanevik

  46. Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome

    Article • BMC Immunology, January 2017, Springer Science + Business Media

    Dr Kurt Hanevik

  47. A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency

    Article • The American Journal of Gastroenterology, August 2016, Springer Science + Business Media

    Dr Kurt Hanevik

  48. Long-Term Consequences of Cryptosporidium and Giardia Gastroenteritis

    Article • Current Tropical Medicine Reports, June 2016, Springer Science + Business Media

    Dr Kurt Hanevik

  49. Editorial Commentary:Giardia lamblia–Pathogen or Commensal?

    Article • Clinical Infectious Diseases, June 2016, Oxford University Press (OUP)

    Dr Kurt Hanevik

  50. Excessive daytime sleepiness, sleep need and insomnia 3 years after Giardia infection: a cohort study

    Article • Sleep Health, June 2016, Elsevier

    Dr Kurt Hanevik

  51. Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis

    Article • Neurogastroenterology & Motility, May 2016, Wiley

    Dr Kurt Hanevik

  52. Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study

    Article • BMC Gastroenterology, November 2015, Springer Science + Business Media

    Dr Kurt Hanevik

  53. Prevalence of Cryptosporidium parvum/hominis, Entamoeba histolytica and Giardia lamblia among Young Children with and without Diarrhea in Dar es Salaam, Tanzania

    Article • PLoS Neglected Tropical Diseases, October 2015, PLOS

    Dr Kurt Hanevik

  54. Human Memory CD4+T Cell Immune Responses against Giardia lamblia

    Article • Clinical and Vaccine Immunology, September 2015, ASM Journals

    Dr Kurt Hanevik

  55. The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome: a controlled study 6 years after acute gastrointestinal infection

    Article • BMC Gastroenterology, June 2015, Springer Science + Business Media

    Dr Kurt Hanevik

  56. Whole genome sequencing of clinical isolates of Giardia lamblia

    Article • Clinical Microbiology and Infection, February 2015, Elsevier

    Dr Kurt Hanevik

  57. Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?

    Article • The American Journal of Gastroenterology, January 2015, Springer Science + Business Media

    Dr Kurt Hanevik, Elena Philippou

  58. Hund som Giardia-kilde i Bergen i 2004 – barking up the wrong tree?

    Article • Tidsskrift for Den norske legeforening, January 2015, Norwegian Medical Association

    Dr Kurt Hanevik

  59. Prevalence and molecular characterisation of human adenovirus in diarrhoeic children in Tanzania; a case control study

    Article • BMC Infectious Diseases, December 2014, Springer Science + Business Media

    Dr Kurt Hanevik

  60. Secondary transmission of Cryptosporidium parvum

    Article • Epidemiology and Infection, October 2014, Cambridge University Press

    Dr Øystein Haarklau Johansen, Dagfinn Skaare, Dr Kurt Hanevik

  61. Irritable Bowel Syndrome and Chronic Fatigue 6 Years After Giardia Infection: A Controlled Prospective Cohort Study

    Article • Clinical Infectious Diseases, August 2014, Oxford University Press (OUP)

    Dr Kurt Hanevik

  62. Genetic diversity of norovirus in hospitalised diarrhoeic children and asymptomatic controls in Dar es Salaam, Tanzania

    Article • Infection Genetics and Evolution, August 2014, Elsevier

    Dr Kurt Hanevik

  63. Management of chronicGiardiainfection

    Article • Expert Review of Anti-infective Therapy, July 2014, Taylor & Francis

    Dr Kurt Hanevik

  64. Comparison of four methods for extracting DNA from dried blood on filter paper for PCR targeting the mitochondrial Plasmodium genome

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, June 2014, Oxford University Press (OUP)

    Dr Kurt Hanevik

  65. Genetic Diversity of Circulating Rotavirus Strains in Tanzania Prior to the Introduction of Vaccination

    Article • PLoS ONE, May 2014, PLOS

    Dr Kurt Hanevik

  66. En ung kvinne med langvarig diaré og slapphet

    Article • Tidsskrift for Den norske legeforening, January 2014, Norwegian Medical Association

    Dr Kurt Hanevik

  67. Giardia-infeksjon kan gi irritabel tarm og kronisk utmattelse

    Article • Tidsskrift for Den norske legeforening, January 2014, Norwegian Medical Association

    Dr Kurt Hanevik

  68. Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course

    Article • BMC Gastroenterology, February 2013, Springer Science + Business Media

    Dr Kurt Hanevik

  69. A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway

    Article • Malaria Journal, January 2013, Springer Science + Business Media

    Dr Kurt Hanevik

  70. The role of arginine and arginine-metabolizing enzymes during Giardia – host cell interactions in vitro

    Article • BMC Microbiology, January 2013, Springer Science + Business Media

    Dr Kurt Hanevik

  71. Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome

    Article • BMC Infectious Diseases, October 2012, Springer Science + Business Media

    Dr Kurt Hanevik

  72. The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years afterGiardiainfection. A historic cohort study

    Article • Scandinavian Journal of Gastroenterology, July 2012, Taylor & Francis

    Dr Kurt Hanevik

  73. Human Cellular Immune Response Against Giardia lamblia 5 Years After Acute Giardiasis

    Article • The Journal of Infectious Diseases, October 2011, Oxford University Press (OUP)

    Dr Kurt Hanevik

  74. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study

    Article • Gut, September 2011, BMJ

    Dr Kurt Hanevik

  75. Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome

    Article • Alimentary Pharmacology & Therapeutics, June 2011, Wiley

    Dr Kurt Hanevik

  76. Giardiasis: The Ever-Present Threat of a Neglected Disease

    Article • Infectious Disorders - Drug Targets, October 2010, Bentham Science Publishers

    Dr Kurt Hanevik

  77. Post epidemic giardiasis and gastrointestinal symptoms among preschool children in Bergen, Norway. A cross-sectional study

    Article • BMC Public Health, March 2010, Springer Science + Business Media

    Dr Kurt Hanevik

  78. Giardiasis – why do the symptoms sometimes never stop?

    Article • Trends in Parasitology, February 2010, Elsevier

    Dr Kurt Hanevik

  79. Relative importance of abnormalities of CCK (cholecystokinin) and 5-HT (serotonin) inGiardia-induced post-infectious irritable bowel syndrome and functional dyspepsia

    Article • Alimentary Pharmacology & Therapeutics, February 2010, Wiley

    Dr Kurt Hanevik

  80. Severity of Giardiainfection associated with post-infectious fatigue and abdominal symptoms two years after

    Article • BMC Infectious Diseases, December 2009, Springer Science + Business Media

    Dr Kurt Hanevik

  81. High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, May 2009, Oxford University Press (OUP)

    Dr Kurt Hanevik

  82. Development of functional gastrointestinal disorders after Giardia lambliainfection

    Article • BMC Gastroenterology, April 2009, Springer Science + Business Media

    Dr Kurt Hanevik

  83. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak

    Article • Clinical Microbiology and Infection, November 2008, Elsevier

    Dr Kurt Hanevik

  84. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway

    Article • Journal of Infection, April 2008, Elsevier

    Dr Kurt Hanevik

  85. Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: A randomized open clinical trial

    Article • Scandinavian Journal of Infectious Diseases, January 2008, Taylor & Francis

    Dr Kurt Hanevik

  86. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection

    Article • Journal of Infection, December 2007, Elsevier

    Dr Kurt Hanevik

  87. Landmine injuries in Eritrea

    Article • BMJ, November 2000, BMJ

    Dr Kurt Hanevik